Published on: November 28, 2024

GOVERNMENT-RUN IN-VITRO FERTILISATION (IVF) CENTRE

GOVERNMENT-RUN IN-VITRO FERTILISATION (IVF) CENTRE

NEWS – In a pioneering initiative, Karnataka’s first government-run in-vitro fertilisation (IVF) centre will be set up at Karnataka Medical College & Research Institute (KMC-RI), Hubballi.

HIGHLIGHTS

Aimed at addressing increasing infertility rates and reducing the financial burden of private fertility treatments

Features of the Proposed IVF Centre

Affordable Treatment Options

  • IVF procedures will be provided free of cost for Below Poverty Line (BPL) patients.
  • Above Poverty Line (APL) cardholders will receive a 30% rebate on treatment costs.
  • Compared to private clinics charging Rs. 1.5-3 lakh, this initiative ensures affordability.

Corporate Social Responsibility (CSR) Funding

  • The clinic will be established and operated through CSR funds.
  • Partner companies are also providing specialised training for staff to ensure quality care.

Factors Driving the Initiative

Rising Infertility Rates

  • Increasing infertility rates, now over 10%, caused by:
    • Delayed pregnancies.
    • Changing lifestyles.
    • Chemical contaminants in food.

Need for Accessible Fertility Care

  • Fertility treatments are expensive and unaffordable for many.
  • Poorer sections often lack access to advanced reproductive technologies.

Key Developments at KMC-RI Hubballi

Clinic Infrastructure and Preparation

  • Tenders for civil works and equipment have been awarded.
  • The clinic will operate under the obstetrics and gynaecology department.

Request for Free Medicines

  • KMC-RI has requested the state government to provide free medicines required during IVF.
  • Medicines are currently not covered under the Ayushman Bharat Arogya Karnataka scheme.

Specialist Staff and Facilities

  • Existing reproductive endocrinologists will be part of the team.
  • Requirement for an embryologist has been identified.

Daily outpatient department (OPD) cases for infertility: 10-15 patients, of which 15% need IVF treatments